Science Explorer Back to mapMap
Discussion
Company · Burnaby · Canada

Xenon Pharmaceuticals (Canada)

xenon-pharma.comROR OpenAlex
Research works
110
▼ 11% vs 2018-21
Citations
4.2k
37.9 per fractional work
Top-10% rate
7.6%
all institutions 10.0%
Open access
58%
world 40%
International
35%
world 18%
Xenon Pharmaceuticals (Canada)

Not ranked overall: Xenon Pharmaceuticals (Canada) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Xenon Pharmaceuticals (Canada) work in?

In 2022-now, 33% of research at Xenon Pharmaceuticals (Canada) is in Life Sciences, 32% in Physical Sciences. Its largest fields are Medicine (30%), Biochemistry, Genetics and Molecular Biology (19%), Computer Science (18%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 10 fractional works · 32.6% of its workBiochemistry, Genetics and Molecular Biology: 6 fractional works · 18.7% of its workMolecular Biology: 5 fractional works · 17.4% of its workGenetics: 0 fractional works · 0.7% of its workCell Biology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 3 fractional works · 10.6% of its workCellular and Molecular Neuroscience: 3 fractional works · 8.3% of its workSensory Systems: 0 fractional works · 1.1% of its workCognitive Neuroscience: 0 fractional works · 0.8% of its workNeurology: 0 fractional works · 0.4% of its workPharmacology, Toxicology and Pharmaceutics: 1 fractional works · 2.4% of its workPharmacology: 0 fractional works · 1.3% of its workPharmaceutical Science: 0 fractional works · 1.1% of its workAgricultural and Biological Sciences: 0 fractional works · 0.6% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.6% of its workImmunology and Microbiology: 0 fractional works · 0.4% of its workImmunology: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysical Sciences: 10 fractional works · 32.3% of its workComputer Science: 5 fractional works · 17.6% of its workComputer Networks and Communications: 3 fractional works · 8.7% of its workInformation Systems: 1 fractional works · 4.3% of its workArtificial Intelligence: 1 fractional works · 2.2% of its workComputational Theory and Mathematics: 1 fractional works · 2.2% of its workHardware and Architecture: 0 fractional works · 0.4% of its workChemistry: 3 fractional works · 9.3% of its workOrganic Chemistry: 2 fractional works · 7.5% of its workInorganic Chemistry: 0 fractional works · 1.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEngineering: 1 fractional works · 2.1% of its workElectrical and Electronic Engineering: 0 fractional works · 1.3% of its workBiomedical Engineering: 0 fractional works · 0.6% of its workAerospace Engineering: 0 fractional works · 0.3% of its workEnvironmental Science: 1 fractional works · 1.8% of its workEcology: 0 fractional works · 1.3% of its workEnvironmental Chemistry: 0 fractional works · 0.6% of its workPhysics and Astronomy: 0 fractional works · 1.2% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.6% of its workRadiation: 0 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.3% of its workBiomaterials: 0 fractional works · 0.3% of its workHealth Sciences: 9 fractional works · 30.6% of its workMedicine: 9 fractional works · 29.5% of its workPsychiatry and Mental health: 3 fractional works · 9.1% of its workPediatrics, Perinatology and Child Health: 1 fractional works · 4.8% of its workOncology: 1 fractional works · 3.0% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 2.2% of its workPharmacology: 0 fractional works · 1.5% of its workSurgery: 0 fractional works · 1.4% of its workNeurology: 0 fractional works · 1.2% of its workHematology: 0 fractional works · 1.2% of its workGenetics: 0 fractional works · 1.1% of its workInfectious Diseases: 0 fractional works · 1.1% of its workEpidemiology: 0 fractional works · 1.0% of its workPhysiology: 0 fractional works · 0.9% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workNursing: 0 fractional works · 1.1% of its workNutrition and Dietetics: 0 fractional works · 1.1% of its workSocial Sciences: 1 fractional works · 4.4% of its workDecision Sciences: 1 fractional works · 4.3% of its workInformation Systems and Management: 1 fractional works · 4.3% of its workPsychology: 0 fractional works · 0.1% of its workALL ITS WORKXenonPharmaceuticals…31fractional works, 2022-now
Life Sciences33%Physical Sciences32%Health Sciences31%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology618.7%
    2. Neuroscience310.6%
    3. Pharmacology, Toxicology and Pharmaceutics12.4%
    4. Agricultural and Biological Sciences00.6%
    5. Immunology and Microbiology00.4%
    1. Computer Science517.6%
    2. Chemistry39.3%
    3. Engineering12.1%
    4. Environmental Science11.8%
    5. Physics and Astronomy01.2%
    6. Materials Science00.3%
    1. Medicine929.5%
    2. Nursing01.1%
    1. Decision Sciences14.3%
    2. Psychology00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.11× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.51× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 0.40× its world share, 0 worksImmunology and Micro…Neuroscience: 6.51× its world share, 3 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 6.75× its world share, 1 worksPharmacology, Toxico…Chemistry: 5.92× its world share, 3 worksChemistryComputer Science: 2.27× its world share, 5 worksComputer ScienceEngineering: 0.14× its world share, 1 worksEngineeringEnvironmental Science: 0.37× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials SciencePhysics and Astronomy: 0.56× its world share, 0 worksPhysics and AstronomyMedicine: 1.54× its world share, 9 worksMedicineNursing: 2.21× its world share, 0 worksNursingDecision Sciences: 4.47× its world share, 1 worksDecision SciencesPsychology: 0.03× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 6.8×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics6.75×1 works
  2. Neuroscience6.51×3 works
  3. Chemistry5.92×3 works
  4. Decision Sciences4.47×1 works
  5. Biochemistry, Genetics and Molecular Biology3.51×6 works
  6. Computer Science2.27×5 works
  7. Nursing2.21×0 works
  8. Medicine1.54×9 works
  9. Physics and Astronomy0.56×0 works
  10. Immunology and Microbiology0.40×0 works
  11. Environmental Science0.37×1 works
  12. Engineering0.14×1 works
  13. Agricultural and Biological Sciences0.11×0 works
  14. Materials Science0.08×0 works
  15. Psychology0.03×0 works

Who are the top researchers at Xenon Pharmaceuticals (Canada)?

Ranked on the quality score, Charles J. Cohen, Daniel P. Sutherlin and Janette Mezeyova lead among researchers whose main affiliation is Xenon Pharmaceuticals (Canada).

  1. 1 Charles J. Cohen Canada · #303,175 worldwide 4.8k citations · 86 works
  2. 2 Daniel P. Sutherlin Canada · #372,363 worldwide 6.1k citations · 72 works
  3. 3 Janette Mezeyova Canada · #697,280 worldwide 1.4k citations · 25 works
  4. 4 Sophia Lin Canada · #779,538 worldwide 1.3k citations · 43 works
  5. 5 Clint Young Canada · #936,076 worldwide 1.5k citations · 28 works
  6. 6 Thilo Focken Canada · #1,124,431 worldwide 1.1k citations · 32 works
  7. 7 Christoph M. Dehnhardt Canada · #1,126,882 worldwide 2k citations · 60 works
  8. 8 Matthew Waldbrook Canada · #1,135,422 worldwide 969 citations · 23 works
  9. 9 Jae Hoon Chang Canada · #1,244,344 worldwide 1.7k citations · 83 works
  10. 10 Samuel J. Goodchild Canada · #1,282,009 worldwide 875 citations · 38 works
All ranked researchers at Xenon Pharmaceuticals (Canada)

What are the most cited papers from Xenon Pharmaceuticals (Canada)?

The most cited paper from Xenon Pharmaceuticals (Canada) is "Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency" (Angela R Brooks-Wilson et al., 1999), with 1,720 citations. Next come "Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia" (1,149) and "Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis" (985).

Most cited papers
#PaperReleasedCitations
1 Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency Angela R Brooks-Wilson et al. · Nature Genetics Aug 1999 1,720
2 Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia Cathryn M. Lewis et al. · The American Journal of Human Genetics ReviewOpen access Jul 2003 1,149
3 Mutations in HFE2 cause iron overload in chromosome 1q–linked juvenile hemochromatosis George V. Papanikolaou et al. · Nature Genetics 30 Nov 2003 985
4 Mitoferrin is essential for erythroid iron assimilation George Shaw et al. · Nature Mar 2006 633
5 Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel Michael S. Watson, Garry R. Cutting, Robert J. Desnick et al. · Genetics in Medicine Open access Sep 2004 480
All 59 most cited papers, with filters and sorting

Which keywords describe research at Xenon Pharmaceuticals (Canada)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Antiepileptic Drugs, Neurological Disorders, Ion Channels, Epilepsy, Inflammation, Seizures, Surgery and Workflow Management.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Antiepileptic Drugs4▲ 149×2 topics
  2. Inflammation3▲ 5.1×7 topics
  3. Ion Channels3▲ 99×3 topics
  4. Neurological Disorders3▲ 20×7 topics
  5. Epilepsy3▲ 88×2 topics
  6. Seizures3▲ 144×2 topics
  7. Surgery3▲ 25×2 topics
  8. Workflow Management3▲ 120×2 topics
  9. Classification3▲ 19×1 topic
  10. Status Epilepticus3▲ 181×1 topic
  11. Membrane Proteins2▲ 105×2 topics
  12. Calcium Channels2▲ 335×1 topic
  13. Cell Signaling2▲ 50×2 topics
  14. Voltage-Gated Channels2▲ 335×1 topic
  15. Synaptic Plasticity2▲ 31×2 topics
  16. Distributed Systems2▲ 38×2 topics
  17. GABAergic2▲ 132×1 topic
  18. Neurotransmission2▲ 132×1 topic
  19. Resource Management2▲ 38×2 topics
  20. Oxidative Stress2▲ 3.6×5 topics
  21. Bioinformatics2▲ 46×2 topics
  22. Machine Learning2▲ 1.62×3 topics
  23. Energy Efficiency2▲ 5.7×5 topics
  24. High-Performance Computing1▲ 57×2 topics
  25. Parallel Computing1▲ 40×2 topics
  26. Big Data1▲ 4.5×2 topics
  27. Cloud Computing1▲ 15×2 topics
  28. Distributed Storage1▲ 161×1 topic
  29. Grid Computing1▲ 133×1 topic
  30. Network Coding1▲ 97×1 topic
  31. Reproducibility1▲ 110×1 topic
  32. Scientific Workflows1▲ 110×1 topic
  33. Task Scheduling1▲ 133×1 topic
  34. Virtualization1▲ 52×2 topics
  35. Pharmacokinetics1▲ 13×2 topics
  36. Calcium Signaling1▲ 43×2 topics
  37. Medicinal Chemistry1▲ 12×2 topics
  38. Metalation1▲ 653×1 topic
  39. Molecular Docking1▲ 26×2 topics
  40. Organometallic Chemistry1▲ 72×1 topic

Which research topics does Xenon Pharmaceuticals (Canada) publish most on?

By volume in 2022-now: Epilepsy research and treatment, Ion channel regulation and function, Neuroscience and Neuropharmacology Research and Distributed and Parallel Computing Systems.

Epilepsy research and treatment: 3 fractional worksIon channel regulation and function: 2 fractional worksNeuroscience and Neuroph…2Neuroscience and Neuropharmacology Research: 2 fractional worksDistributed and Parallel…1Distributed and Parallel Computing Systems: 1 fractional worksAdvanced Data Storage Technologies: 1 fractional worksScientific Computing and Data Management: 1 fractional worksCoordination Chemistry a…1Coordination Chemistry and Organometallics: 1 fractional worksPharmacological Effects and Toxicity Studies: 1 fractional worksCloud Computing and Resource Management: 1 fractional worksSecurity and Verification in Computing: 1 fractional works
Psychiatry and Mental healthMolecular BiologyCellular and Molecular NeuroscienceComputer Networks and Communications5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Epilepsy research and treatment Psychiatry and Mental health 3 works
  2. 2 Ion channel regulation and function Molecular Biology 2 works
  3. 3 Neuroscience and Neuropharmacology Research Cellular and Molecular Neuroscience 2 works
  4. 4 Distributed and Parallel Computing Systems Computer Networks and Communications 1 works
  5. 5 Advanced Data Storage Technologies Computer Networks and Communications 1 works
  6. 6 Scientific Computing and Data Management Information Systems and Management 1 works
  7. 7 Coordination Chemistry and Organometallics Organic Chemistry 1 works
  8. 8 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 1 works
  9. 9 Cloud Computing and Resource Management Information Systems 1 works
  10. 10 Security and Verification in Computing Artificial Intelligence 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available58.5%not open41.5%

World: 40% of research is openly available.

with international co-authors35.1%domestic only64.9%

World: 18% is written across borders.

How has Xenon Pharmaceuticals (Canada)'s research output changed?

Output in 2022-2025 was 11% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Xenon Pharmaceuticals (Canada) as a percentage of every work published that year, 0.00012% in 2024.

still counting0.00020%0.00040%Xenon Pharmaceuticals (Canada)0.00020% in 202519801990200020102020

Fractional works of Xenon Pharmaceuticals (Canada) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Burnaby

All research institutions in Burnaby

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Xenon Pharmaceuticals (Canada). Posts are plain text and can be reported.